Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Preventive Analgesia With Anrikefon in Laparoscopic Gallbladder Surgery

Official title: Effect of Preventive Analgesia With Anrikefon on Postoperative Acute Pain and Rehabilitation Process in Adult Patients Undergoing Laparoscopic Cholecystectomy

Run by Xuanwu Hospital, Beijing · NCT07566663 · Data updated 2026-11-12

This study tests whether giving Anrikefon before or during laparoscopic cholecystectomy can reduce early postoperative pain.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment274 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJune 2, 2026
Main results expectedMay 31, 2028
Study endsJune 30, 2028
Registry record updatedJuly 1, 2026
Trial IDNCT07566663 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-65 undergoing elective laparoscopic cholecystectomy with ASA I–III.

Probably not a fit

Patients with certain comorbidities or prior adverse reactions to similar medications may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, double-blind, randomized trial compares two timing strategies of Anrikefon administration for preventive analgesia in adults undergoing laparoscopic cholecystectomy. Participants are randomly assigned to preventive analgesia or bridging analgesia in a 1:1 ratio. The primary endpoint is the time-weighted sum of pain intensity differences over the first 24 hours after surgery, measured by NRS at multiple post-op time points. The study aims to clarify timing for optimal pain control while monitoring recovery quality. Safety and tolerability of Anrikefon with limited central effects are also assessed.

Why it matters

Potential benefit: If successful, the approach could reduce early postoperative pain and improve recovery after laparoscopic cholecystectomy.

How similar studies have gone: Prior research on Anrikefon for preventive analgesia in this setting is limited, making this study a relatively novel evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. ASA physical status classification I-III;
2. Age 18-65 years;
3. Scheduled for elective laparoscopic cholecystectomy;
4. Voluntary signed informed consent;
5. BMI between 18-28 kg/m²;
6. No history of general anesthesia surgery within the past 3 months.

Exclusion Criteria:

1. Severe cardiovascular disease, respiratory disease, or psychiatric disorders;
2. Severe renal insufficiency;
3. Recent use of diuretics or compound medications containing diuretics;
4. Continuous use of opioid analgesics for more than 10 days within the past 3 months;
5. Use of medications with unknown half-life affecting analgesic efficacy within 14 days prior to randomization;
6. Pregnant women, lactating women, or those planning pregnancy in the near future;
7. History of hypersensitivity to study medications.

Where it's running

  • Xuanwu Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.